CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...